The American Medical Association reports that about 30 million people in the US live with sleep apnea, but only one-fifth of these cases are clinically diagnosed. That means that many people are ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images Sleep ...

Though the American Medical Association reports that about 30 million people in the US live with sleep apnea, only one-fifth of these cases are clinically diagnosed. This is concerning because living ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...

A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ...

Sleep apnea causes breathing to pause and restart during sleep. Obstructive sleep apnea (OSA) is a physical upper-airway blockage, while central sleep apnea (CSA) involves abnormal brain signaling.

New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...

A once-nightly oral pill helped control obstructive sleep apnea in a large, phase 3 clinical trial presented at the 2026 ATS International Conference.

Positional therapy can be a long-lasting and effective treatment for patients with positional obstructive sleep apnea (OSA), according to research presented at the 2026 ATS International Conference.

Sleep apnea causes breathing to stop and start during sleep, leading to snoring and daytime sleepiness. Untreated sleep apnea may raise stroke, heart failure, and high blood pressure risk. Continuous ...